“… In asymptomatic patients ≥12 years old without risk factors for severe COVID-19, we suggest the use of laboratory-based NAAT versus rapid antigen testing for the diagnosis of COVID-19. | Weak against | Low | [ 11 , 20 , 49 , 54 , 55 , 65 , 70 , 71 , 77 , 83 , 89 , 94 , 22 , 111 , 113 , 121 , 128 , 130 , 137 , [143] , [144] , [145] , [146] , 24 , [147] , [148] , [149] , 158 , [160] , [161] , [162] , [163] , [164] , [165] , 28 , [166] , [167] , [168] , [169] , [170] , [171] , [172] , [173] , [174] , [175] , 34 , 176 , 40 , 43 , 44 , 46 ] | 3 | In asymptomatic people of any age with any risk factor(s) for severe COVID-19 (including age <3 or ≥65 years) should rapid antigen tests be used, as compared to laboratory-based ... |
…”